HHS Nominee Tom Price Struggles to Account for Questionable Stock Purchases
President-elect Donald Trump’s pick to head the Department of Health and Human Services came out of a confirmation hearing on Wednesday battered by questions about his financial dealings. Members of the Senate Health, Education, Labor and Pension Committee picked up on critical reporting showing that HHS nominee Rep. Tom Price (R-Ga.) purchased stock in healthcare companies while simultaneously pushing legislation to benefit those same firms. Sen. Patty Murray (D-Wash), the ranking Democrat on the panel, specifically pressed Price about his investments in a biotech company…